• Policy
• Daewoong sells the original Ebixa
• by Lee, Tak-Sun Aug 1, 2022 09:16pm

• Policy
• MFDS Minister promises COVID-19 vaccineˑTx support
• by Lee, Hye-Kyung Aug 1, 2022 05:58am

• Policy
• MFDS announces a series of tasks for innovation
• by Lee, Hye-Kyung Jul 29, 2022 05:51am

• Policy
• 500 billion won fund by the end of this year
• by Lee, Jeong-Hwan Jul 28, 2022 05:54am

• Policy
• Outpatient tx 14.7 times a year per person in Korea
• by Kim, Jung-Ju Jul 28, 2022 05:54am

• Policy
• The revised COVID-19 in vitro diagnostic device guidelines
• by Lee, Hye-Kyung Jul 27, 2022 05:50am

• Policy
• COVID-19 improved vaccines will be promoted
• by Kim, Jung-Ju Jul 27, 2022 05:49am

• Policy
• Paxlovid·Lagevio, the effect of inhibiting viral proliferat
• by Kim, Jung-Ju Jul 25, 2022 05:57am

• Policy
• Donepezil patch is cheaper than 99 existing formulations
• by Lee, Tak-Sun Jul 22, 2022 05:53am

• Policy
• Drug e-labeling and abolition of PMS reexaminations...
• by Lee, Hye-Kyung Jul 22, 2022 05:53am